首页> 外文会议>Context Sensitive Health Informatics Conference. >Medication Review: Human Factors Study Aiming at Helping an Acute Geriatric Unit to Sustain and Systematize the Process
【24h】

Medication Review: Human Factors Study Aiming at Helping an Acute Geriatric Unit to Sustain and Systematize the Process

机译:药物评论:人类因素研究,旨在帮助急性老年特性单位维持和系统化过程

获取原文

摘要

Background: Medication Review (MRev) has been implemented in many hospitals to improve patient safety and well-being. However, it seems sometimes difficult to implement, maintain and systematize this process, especially when key-elements are absent. This study focuses on the analysis of a MRev process implemented in an Acute Geriatric Unit (AGU) which, at the time of the study, had no Computerized Physician Order Entry (CPOE) and no sufficient staff to - normally - support the process. Objective: This study describes the MRev process as existing in the AGU with a particular focus on the preparatory MRev meeting phase and presents our recommendations to maintain and optimize it. Methods: Human Factor experts have collected and analyzed data during MRev process by interviews, shadowing observations and video recording from April to October 2014 at Lille University Hospital. Results: MRev process consists of three phases (meeting preparation, MRev meeting and patient discharge) and includes seven main tasks for which actors, documented supports, outcomes and difficulties are identified. Although allocating a fulltime pharmacist for the AGU would solve several problems, the main realistic recommendations concern training for junior and senior actors according to their roles and the improvement of some tasks processes. Conclusion: Despite less than optimal conditions as compared to those recommended by the literature, the observed AGU performs an efficient review based on well designed tools and processes.
机译:背景:药物评论(MREV)已在许多医院实施,以改善患者的安全和福祉。但是,有时难以实现,维护和系统化此过程,尤其是当关键元素不存在时。本研究重点介绍了在研究中实施的MREV过程的分析,在研究时,在研究时没有电脑医生订单进入(CPE),并且通常没有足够的工作人员 - 通常支持该过程。目的:本研究描述了AGU中存在的MREV过程,特别关注筹备MREV会议阶段,并呈现我们的建议,以维持和优化它。方法:通过在2014年4月至2014年10月在里尔大学医院的访谈,阴影观察和视频录制期间,人类因子专家在MREV过程中收集和分析了数据。结果:MREV流程由三个阶段(会议准备,MREV会议和患者院)组成,包括七个主要任务,其中举办了行动者,记录的支持,结果和困难。虽然为AGU分配全职药剂师将解决几个问题,但主要的现实建议涉及初级和高级行动者的培训,根据其角色和改进一些任务流程。结论:尽管与文献推荐的那些相比,但观察到的AGU基于精心设计的工具和流程进行了有效的审查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号